Mesoblast Ltd expected to post a loss of 15 cents a share - Earnings Preview

Mesoblast

23/02/2024 11:28

* Mesoblast Ltd  MSB.AX   is expected to show a rise in
quarterly
revenue when it reports  results on February 22 (estimated) for
the period ending September 30 2023
    * The Melbourne Victoria-based  company is expected to
report a
19.8% increase in revenue to $1.8 million from $1.5 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Mesoblast Ltd is for a
loss
of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Mesoblast
Ltd is
A$0.57​, above​ its last closing price of A$0.29. ​​​

This summary was machine generated February 23 at 11:28 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)